Course selection: Medical and Pharmaceutical Aspects of Biotechnology
1655-Lek21WYBBIO-J
The subject “Medical and pharmaceutical aspects of biotechnology” is conducted in the form of seminars. The main topic is the development of new formulas of biotechnological products and their use in medical practice and the pharmaceutical industry. During the seminars, basic information on aspects of medical biotechnology will be explained. Students will also gain knowledge about personalizing therapy with the use of biotechnological products. Additionally, students will get to know each other with the applicable regulations on the registration of new drugs and medical devices.
Total student workload
Study hours involving teacher participation:
- seminars – 15 hours
- examination – 1 hour
Total workload involving the direct participation of academic teachers: 16 hours, which equals 0.64 of an ECTS point.
Study hours involving individual student work:
- seminars – 15 hours
- preparation for seminars – 3 hours
- preparation for examination and exam – 6 + 1 hours
Total student workload: 25 hours, which equals 1 ECTS point.
Workload associated with research:
- reading of scientific literature: 1.5 hours
- participation in seminars (related to research in the field of pharmaceutical aspects and biotechnology): 15 hours
- final test preparation (related to research in the field of pharmaceutical aspects and biotechnology): 2.5 hours
Total student workload associated with research: 19 hours, which equals 0.76 ECTS point.
Time requirements for preparation and participation in the student assessment process:
- preparation for final test: 5.5 + 1 = 6.5 hours (0.26 of an ECTS point).
Student workload connected to distant learning methods: not applicable
Student workload connected to practical skills classes:
- participation in tutorials: 15 hours (0.6 of an ECTS point)
Time required to complete the obligatory internship: not applicable
Learning outcomes - knowledge
W1: Explains the use and importance of stem cells in medical biotechnology (B.W19)
W2: Identifies the possibilities of using biotechnological products
in modeling human diseases (C.W42)
W3: Defines the use of biologically active compounds in targeted therapy (C.W42)
Learning outcomes - skills
U1: Is able to creatively and critically define the scope of research,
also of an interdisciplinary nature, formulate their goals and select appropriate research tools to verify the hypotheses (B.U12)
U2: Analyzes the results of conducted experiments and draws correct conclusions (B.U13)
Learning outcomes - social competencies
K1: Is willing to deepen knowledge and improve own skills (K.K1)
K2: Shows interest in updating his knowledge (K.K8)
Teaching methods
Seminars:
• problem lecture
• seminar lecture
• didactic discussion
Expository teaching methods
- problem-based lecture
- discussion
Exploratory teaching methods
- classic problem-solving
- seminar
- expert panels
Online teaching methods
- methods referring to authentic or fictitious situations
- methods developing reflexive thinking
- exchange and discussion methods
Type of course
auxiliary course (attribute withdrawn)
Prerequisites
Elementary knowledge of cell biology.
Course coordinators
Term 2022/23Z: | Term 2023/24Z: | Term 2024/25Z: |
Assessment criteria
extended follow-up (0-10 points; > 50%): K1-K
Practical placement
Bibliography
Basic literature:
1.Rosier JA, Martens MA, Thomas JR. Global New Drug Development: An Introduction. Wiley-Blackwell, 2014.
2. NCBI databases, e.g. PubMed
Supplementary literature:
1. Wenyi Z. Handbook for Chemical Process Research and Development. Taylor&Francis Inc, 2016.
2. Bleavins MR. Biomarkers in Drug Development. John Wiley & Sons Ltd., 2010.
3. Turner JR. New Drug Development: An Introduction to Clinical Trials: Second Edition. Springer, 2010.
4. Thurston DE. Chemistry and Pharmacology of Anticancer Drugs. CRC Press, 2006.
Additional information
Additional information (registration calendar, class conductors,
localization and schedules of classes), might be available in the USOSweb system: